Search research articles
Contact Us
Filters
Showing results (41-50 of 117) with videos related to
Page
of 12
Sort By:
NMR in Biomedicine
|
November 13, 2024
Orientation-independent quantification of macromolecular proton fraction in tissues with suppression of residual dipolar coupling
Zijian Gao, Ziqiang Yu, Ziqin Zhou, et al.
Current Oncology (Toronto, Ont.)
|
July 25, 2022
Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
Irena Druce, Karine Tawagi, Julie L V Shaw, et al.
Journal of General Internal Medicine
|
September 25, 2025
A Novel Intervention for Medicaid Beneficiaries with Complex Needs
Luke Mueller, Neil Batlivala, Jonathan Palisoc, et al.
Journal of the American Academy of Dermatology
|
March 14, 2024
Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
Rachel C Hill, Yu Wang, Bilal Shaikh, et al.
Cancer Chemotherapy and Pharmacology
|
April 3, 2020
Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer
Igal Kushnir, Ranjeeta Mallick, Michael Ong, et al.
Medical Oncology (Northwood, London, England)
|
January 23, 2019
The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity
Igal Kushnir, Kim Koczka, Michael Ong, et al.
Nature Reviews. Clinical Oncology
|
October 17, 2013
Appraising iniparib, the PARP inhibitor that never was--what must we learn?
Joaquin Mateo, Michael Ong, David S P Tan, et al.
Journal of Public Health Management and Practice : JPHMP
|
May 29, 2012
The public health disaster trust scale: validation of a brief measure
David P Eisenman, Malcolm V Williams, Deborah Glik, et al.
Cancers
|
April 30, 2021
Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review
Kerianne Boulva, Sameer Apte, Ashley Yu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 9, 2022
Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario
Fred Saad, Bimal Bhindi, Krista Noonan, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 117) with videos related to
Sort By:
Page
of 12
NMR in Biomedicine
|
November 13, 2024
Orientation-independent quantification of macromolecular proton fraction in tissues with suppression of residual dipolar coupling
Zijian Gao, Ziqiang Yu, Ziqin Zhou, et al.
Current Oncology (Toronto, Ont.)
|
July 25, 2022
Routine Screening for Central and Primary Adrenal Insufficiency during Immune-Checkpoint Inhibitor Therapy: An Endocrinology Perspective for Oncologists
Irena Druce, Karine Tawagi, Julie L V Shaw, et al.
Journal of General Internal Medicine
|
September 25, 2025
A Novel Intervention for Medicaid Beneficiaries with Complex Needs
Luke Mueller, Neil Batlivala, Jonathan Palisoc, et al.
Journal of the American Academy of Dermatology
|
March 14, 2024
Spironolactone treatment for dermatologic indications is not associated with hypotension in a single-center retrospective study
Rachel C Hill, Yu Wang, Bilal Shaikh, et al.
Cancer Chemotherapy and Pharmacology
|
April 3, 2020
Docetaxel dose-intensity effect on overall survival in patients with metastatic castrate-sensitive prostate cancer
Igal Kushnir, Ranjeeta Mallick, Michael Ong, et al.
Medical Oncology (Northwood, London, England)
|
January 23, 2019
The timing of docetaxel initiation in metastatic castrate-sensitive prostate cancer and the rate of chemotherapy-induced toxicity
Igal Kushnir, Kim Koczka, Michael Ong, et al.
Nature Reviews. Clinical Oncology
|
October 17, 2013
Appraising iniparib, the PARP inhibitor that never was--what must we learn?
Joaquin Mateo, Michael Ong, David S P Tan, et al.
Journal of Public Health Management and Practice : JPHMP
|
May 29, 2012
The public health disaster trust scale: validation of a brief measure
David P Eisenman, Malcolm V Williams, Deborah Glik, et al.
Cancers
|
April 30, 2021
Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review
Kerianne Boulva, Sameer Apte, Ashley Yu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
December 9, 2022
Assessment of the epidemiological trends for prostate cancer using administrative data in Ontario
Fred Saad, Bimal Bhindi, Krista Noonan, et al.
Page
of 12